93 related articles for article (PubMed ID: 8815027)
1. [Angiotensin-converting enzyme inhibitors in liver function disorders?].
Bönner G
Dtsch Med Wochenschr; 1996 Feb; 121(8):254. PubMed ID: 8815027
[No Abstract] [Full Text] [Related]
2. Angiotensin-converting enzyme inhibition in cirrhotic patients--pharmacokinetics of ramipril.
Pidlich J; Cichini GM; Reinisch W; Peck-Radosavljevic M; Renner F
Acta Med Austriaca; 1997; 24(1):15-8. PubMed ID: 9150805
[TBL] [Abstract][Full Text] [Related]
3. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.
López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
Eur Heart J; 2004 Aug; 25(16):1454-70. PubMed ID: 15302105
[No Abstract] [Full Text] [Related]
4. Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
El-Demerdash E; Salam OM; El-Batran SA; Abdallah HM; Shaffie NM
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):159-67. PubMed ID: 17900296
[TBL] [Abstract][Full Text] [Related]
5. [ACE inhibitors in the treatment of patients with arterial hypertension and pathology of the digestive system].
Lazebnik LB; Mikheeva OM; Komissarenko IA; Drozdov VN; Petrakov AV; Sil'vestrova SIu
Eksp Klin Gastroenterol; 2007; (4):47-55. PubMed ID: 18409490
[No Abstract] [Full Text] [Related]
6. Impact of disease states on the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors.
LeBlanc JM; Dasta JF; Pruchnicki MC; Schentag JJ
J Clin Pharmacol; 2006 Sep; 46(9):968-80. PubMed ID: 16920891
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil hypersegmentation in children receiving angiotensin converting enzyme inhibitors.
Okutan V; Kürekçi AE; Sarici SU; Atay AA; Yozgat Y; Azik F; Lenk MK; Ozcan O
Turk J Pediatr; 2008; 50(5):438-42. PubMed ID: 19102047
[TBL] [Abstract][Full Text] [Related]
8. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
Quan A
Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
[TBL] [Abstract][Full Text] [Related]
10. Acute hypotensive transfusion reaction during liver transplantation in a patient on angiotensin converting enzyme inhibitors from low aminopeptidase P activity.
Doria C; Elia ES; Kang Y; Adam A; Desormeaux A; Ramirez C; Frank A; di Francesco F; Herman JH
Liver Transpl; 2008 May; 14(5):684-7. PubMed ID: 18433037
[TBL] [Abstract][Full Text] [Related]
11. [Aspirin, angiotensin converting enzyme inhibitors and cardiac insufficiency].
de Groote P; Aumégeat V; Meurice T; Millaire A; Lamblin N; Lablanche JM
Arch Mal Coeur Vaiss; 2000 Feb; 93(2):167-71. PubMed ID: 10830093
[TBL] [Abstract][Full Text] [Related]
12. [How to evaluate hepatic function: pharmacokinetic approach].
Malè PJ
Rev Med Suisse Romande; 1985 Apr; 105(4):313-6. PubMed ID: 4012141
[No Abstract] [Full Text] [Related]
13. [Use of angiotensin converting enzyme inhibitors in nephrology].
Stefanović V; Ivić M; Bogićević M
Srp Arh Celok Lek; 1994; 122(7-8):228-30. PubMed ID: 17974394
[TBL] [Abstract][Full Text] [Related]
14. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function.
Ray JG
Can J Cardiol; 1997 Aug; 13(8):780-1, 783. PubMed ID: 9284846
[No Abstract] [Full Text] [Related]
16. Progress in the development of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Singh RK; Barker S
Curr Opin Investig Drugs; 2005 Mar; 6(3):269-74. PubMed ID: 15816503
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of angiotensin receptor antagonists and angiotensin converting enzyme inhibitors in arterial hypertension].
Krezsinski JM; Sternon J
Rev Med Brux; 2000 Jun; 21(3):170-7. PubMed ID: 10925600
[TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis: a balance of ACEs?
Warner FJ; Lubel JS; McCaughan GW; Angus PW
Clin Sci (Lond); 2007 Aug; 113(3):109-18. PubMed ID: 17600527
[TBL] [Abstract][Full Text] [Related]
19. [Cough is a frequent side effect in treatment with ACE-inhibitors].
Backström M
Vardfacket; 1997 Dec; 21(11):44-7. PubMed ID: 9483138
[No Abstract] [Full Text] [Related]
20. [Antiarrhythmic properties of angiotensin converting enzyme inhibitors].
Dzielska-Olczak M
Wiad Lek; 1998; 51(9-10):424-9. PubMed ID: 9921106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
